AJP - Endo Watch the video to learn how APS reaches out to developing nations.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Endocrinol Metab 275: E821-E829, 1998;
0193-1849/98 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Genter, P.
Right arrow Articles by Ipp, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Genter, P.
Right arrow Articles by Ipp, E.
Vol. 275, Issue 5, E821-E829, November 1998

Counterregulatory hormones oscillate during steady-state hypoglycemia

Pauline Genter1,2, Nancy Berman1, Mary Jacob2, and Eli Ipp1

1 Department of Medicine and Pediatrics, Harbor-University of California Los Angeles Medical Center, Torrance 90509; and 2 California State University at Long Beach, Long Beach, California 90840

During hypoglycemia, the magnitude of the counterregulatory response depends on the extent of plasma glucose reduction. However, our clinical observations during steady-state hypoglycemia indicate that symptom severity can change independently of plasma glucose concentrations, i.e., symptoms appeared to fluctuate despite stable glucose levels. This study was therefore designed to test the hypothesis that hormonal and symptomatic responses to hypoglycemia are pulsatile. Seven healthy subjects had serial blood sampling at 3-min intervals during 90 min of insulin-induced hypoglycemia. Mean ± SE plasma glucose levels plateaued at 62 ± 3 mg/dl. Counterregulatory hormones were significantly elevated (P < 0.05-0.01, except norepinephrine) and strikingly pulsatile. Cluster analysis revealed pulses of large magnitude in plasma glucagon, epinephrine, and norepinephrine concentrations. Amplitudes were, respectively, 72 ± 4, 64 ± 8, and 48 ± 3% of the mean. Interpeak intervals were 27 ± 7, 19 ± 4, and 25 ± 5 min, respectively. Symptom score and cardiovascular responses were also pulsatile; their peaks were found to coincide with epinephrine peaks. We conclude that hormonal and symptomatic counterregulation in hypoglycemia, while critically driven by plasma glucose levels, is also influenced by an endogenous pulsatility that exists despite steady-state glucose concentrations.

glucose homeostasis; pulsatility; pulse analysis


This article has been cited by other articles:


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
L. S. Farhy, Z. Du, Q. Zeng, P. P. Veldhuis, M. L. Johnson, K. L. Brayman, and A. L. McCall
Amplification of pulsatile glucagon counterregulation by switch-off of {alpha}-cell-suppressing signals in streptozotocin-treated rats
Am J Physiol Endocrinol Metab, September 1, 2008; 295(3): E575 - E585.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
J. F. Horowitz, A. E. Kaufman, A. K. Fox, and M. P. Harber
Energy deficit without reducing dietary carbohydrate alters resting carbohydrate oxidation and fatty acid availability
J Appl Physiol, May 1, 2005; 98(5): 1612 - 1618.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online